Description
Indication & Scope
JunShiDa® Ongericimab Injection lowers LDL-cholesterol for patients with primary non-familial hypercholesterolemia and mixed dyslipidemia.
- Mechanism: PCSK9 inhibitory monoclonal antibody upregulates hepatic LDL receptors, accelerates the clearance of low-density lipoprotein cholesterol in blood circulation.
- Drug class: PCSK9 inhibitor, injectable lipid-lowering biologic drug.
- Clinical use: Lipid-lowering treatment for statin-intolerant patients or patients needing intensified LDL reduction.
| Generic Name | Ongericimab Injection |
| Brand Name | JunShiDa |
| Ingredient | Ongericimab Injection |
| Dosage Form | Injection |
| Package | 150mg(1ml)*1 syringe/box |
| Conditions Treated | Primary non-familial hypercholesterolemia, mixed dyslipidemia |
| Taboos | 1. Known severe hypersensitivity to ongericimab or formulation components
2. Severe decompensated liver failure 3. Unexplained severe myalgia and rhabdomyolysis |
| Place of origin | China |
| Priscription Type | Prescription-only |
| Storage Conditions | 2°C ~ 8°C refrigeration, avoid freezing and direct sunlight |
| Manufacturer | BoChuang Pharmaceutical ,Ltd |
| Registration Authority | National Medical Products Administration (NMPA) |
| Approval number | S20240047 |
| Approval Date | Oct 9, 2024 |
| Shelf Life | 24 months |
How to use ?
Recommended Dose: Low-frequency fixed maintenance subcutaneous injection dose.
Time: Long-term chronic lipid control with scheduled dosing intervals.
Instructions for use: Subcutaneous injection into abdomen, thigh or upper arm.
Interaction: Safe combined administration with statins and oral lipid-lowering agents without dose adjustment.
Side effects: Injection site reactions, headache, myalgia, mild flu-like symptoms.
Important Notice
This product shall only be used for post-exposure rabies prophylaxis by professional medical staff. It must be applied combined with rabies vaccine and injected via wound infiltration plus intramuscular routes as specified. Do not administer intravenously or alter the dosage at will. Hypersensitivity monitoring is required throughout the whole injection process.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What is the clinical application of Ongericimab Injection?
It is used to lower LDL cholesterol in patients with primary non-familial hypercholesterolemia and mixed dyslipidemia.
Is it safe to combine Ongericimab Injection with statins?
Yes, it can be safely co-administered with statins and oral lipid-lowering drugs without additional dose adjustment.
What are the main contraindications of Ongericimab Injection?
It is forbidden for patients with severe drug hypersensitivity, decompensated liver failure and severe unexplained myalgia.
What mild adverse reactions may occur clinically when using Ongericimab Injection?
Common side effects include injection site reactions, headache, myalgia and mild flu-like symptoms.
JunShiDa® | Ongericimab Injection | Hypercholesterolemia and Mixed Dyslipidemia | DengYueRX
INN: Ongericimab Injection
Indications: Hypercholesterolemia (non familial) and mixed dyslipidemia
Dosage Form:
Strength: 150mg(1ml)/syringe
